This UBC-developed website educates youth on when period pain is too much
The website Period Pain is Real Pain, which was created with the input of youth partners, includes resources about period pain, related conditions like endometriosis, and pain relief.
It also features a free quiz that helps youth determine whether they should speak to a health-care provider about their pain.
UBC PhD student and campaign developer Zeba Khan, who studies period pain care in Canada, said period pain is a very common experience, one that affects more than 60 per cent of females of reproductive age.
"Despite being so common, there is this narrative that period pain is normal and 'it's just part of being a woman,'" Khan said. "And that narrative is harmful because it makes it difficult to talk about period pain and get the right support."
Khan said period pain can be most intense during adolescence.
"We want young people to know that their pain is valid. So we hope that this tool, the website, the campaign will help young people recognize what the options are for them."
She added that young people should speak with their health-care providers if their pain is so severe that it stops them from participating in day-to-day activities like going to school or playing sports.
Dr. Paul Yong, associate professor of obstetrics and gynecology at UBC, said untreated recurring period pain in adolescence could be a risk factor for chronic pain in the future.
"We really think that prevention is really key, in terms of chronic pain, so that's why we have such interest in the adolescence time … not only to help the lives right now of adolescents, but also to prevent that pain from worsening in the future."
Endometriosis, a condition in which tissue similar to the inner lining of the uterus grows outside the uterus, is one of the most common underlying causes of period pain, according to Yong.
It affects about one in 10 females of reproductive age.
Vancouver-based endometriosis advocate Lux Perry, CEO and founder of Somedays, a natural period-pain relief company, said a resource website like Period Pain is Real Pain can help people decipher their experiences in a tangible way.
"Any resource … is just so pivotal to someone's ability to be able to advocate for themselves and communicate with doctors."
Her experience as a young teen with endometriosis was "extremely painful."
"I was unable to go to school; I was unable to participate in sports. It completely disrupted my ability to go about my normal life," Perry said.
Cally Wesson, president and CEO of B.C. Women's Health Foundation, which provided funding for the research project, praised the website.
She said women's pain experiences can often be dismissed by health-care professionals.
"So getting information out about period pain is really important because it validates the symptoms that women are going through."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
5 hours ago
- Epoch Times
FDA Advises Americans Against ‘Mousse' Sunscreens, Warns 5 Manufacturers
Americans should 'beware' of sunscreen products in mousse form as they may not be effective, the Food and Drug Administration (FDA) said in an Aug. 12 X post, with the agency sending warning letters to five companies marketing sunscreen products. The letters were sent on Aug. 6 to Texas-based Supergoop, Pennsylvania-based Fallien Cosmeceuticals Ltd., Israel-based K & Care Organics, Sweden-based Kalani AB, and Florida-based Vacation Inc.
Los Angeles Times
8 hours ago
- Los Angeles Times
Unlocking Cellular Health With Science and Trust
In the longevity and wellness space, Niagen Bioscience is charting a course defined by both scientific rigor and an unwavering commitment to responsible innovation Niagen Bioscience (NASDAQ: NAGE, formerly Chromadex) is a Los Angeles-based company dedicated to advancing the supplements industry using science-backed research into their component ingredients. At the helm is CEO Robert Fried, who says the company's mission is to pioneer NAD+ research and develop transformative NAD-boosting healthy-aging solutions with Niagen, their patented form of nicotinamide riboside (NR). Niagen is the cornerstone of the company's clinically proven product portfolio, Tru Niagen and Niagen IV and injections. During this year's Cannes Lions, Fried sat down with LA Times Studios to discuss how the company is pioneering the NAD+ space and the science and quality backed benefits of its Niagen products. 'NAD+, or nicotinamide adenine dinucleotide, is a co-enzyme found in all living cells – plant and animal – and is involved in all important metabolic processes within the cell, but especially energy metabolism and DNA repair, which are key to supporting mitochondrial health and overall optimal health.' explained Fried. Mitochondria, the 'battery pack of the cell,' combines nutrients from the food you eat and oxygen with NAD+ to produce energy. NAD+ also plays a crucial role in DNA recovery and cellular repair. 'All of these processes that exist within the cell where the cell repairs damage are NAD+ dependent,' Fried emphasized, illustrating how higher NAD+ levels facilitate rapid healing, contrasting youthful recovery with a slower healing process that occurs as we age. This is because NAD+ starts to decline naturally in our 30s, with research showing a dramatic drop of up to 65% by the time we reach age 70. Exposure to stressors like sedentary lifestyle, excess sun exposure, poor diet and environmental factors also impact NAD+ levels. Research shows that NAD+ decline is associated with a decline in overall health and vitality, contributing to the development of conditions and disease. Fried is quick to address a significant industry misconception: 'NAD+ itself is not bioavailable. If you consume NAD+ orally or with an IV, it will not elevate NAD+ levels inside your cells.' He clarified that the NAD+ molecule is too large to penetrate cells, causing NAD+ supplements and IV to be ineffective. Intact NAD+ may even have the potential to cause acute immune inflammatory response, which may be responsible for the uncomfortable side effects associated with NAD+ IV and injections. The solution, according to Fried, is 'to consume an NAD+ precursor molecule that easily gets into the cell and then converts into NAD+, and the best molecule for this is called nicotinamide riboside or NR.' Niagen is patented NR and precisely what Tru Niagen and pharmaceutical-grade Niagen IV and injections offer. With a legacy spanning over 25 years, the company's recent rebranding from ChromaDex to Niagen Bioscience reflects its sharpened focus. 'We're no longer only a reference standards company but an NAD+ company dedicated to addressing one of life's most complex challenges - aging,' said Fried. Niagen Bioscience differentiates itself by operating as an 'R&D lab that specializes in NAD+,' not simply a supplement distributor, he said. Its distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and an external research program helping independent investigators and institutions worldwide uncover the potential of NAD+. 'There is no other company in the supplement space that comes close this level of R&D investment and scientific research,' Fried asserted. The company boasts 38 peer-reviewed, published human clinical studies on oral food-grade Niagen, of which about 95% are completely independent, with another 40 studies currently underway. This level of scientific rigor, he contends, is typically found only in biotech or pharmaceutical companies. Products are tested at the manufacturing facility and then retested upon delivery. Fried notes their marketing: 'We are real. We are genuine. We let the science do the talking.' This approach, he believes, is key to building genuine trust. Niagen Bioscience is exploring Niagen's broader therapeutic potential for its patented NR. Fried reveals extensive clinical studies on the benefits of its patented food-grade NR for specific age-related and orphan diseases (rare conditions characterized by rapid aging). Some of these studies have reached Phase II and III clinical trials. A 52 week, 400-participant, Phase III double-blinded, controlled study on Parkinson's disease recently concluded, conducted with a world-renowned independent researcher. 'That is a level of scientific research ... that you don't see from supplement companies,' Fried emphasized. Niagen Bioscience is also innovating beyond oral supplements. They've developed a pharmaceutical-grade version of nicotinamide riboside, now available as Niagen IV. exclusively at clinics across the U.S. Fried highlighted its advantages: 'If you do an injection or an IV, you're getting the benefits of Niagen directly to the bloodstream.' This results in faster absorption and avoids side effects often associated with direct NAD+ infusions. Fried candidly addresses his concern about a lack of public trust in the dietary supplement industry, citing prevalent unsubstantiated claims, low-quality products, and marketing hype. 'It's my belief that if people genuinely trusted the companies that the industry at large would be so significant because we'd actually have preventative health value,' he states. To combat this, Niagen Bioscience has proposed a 'Trust Alliance' – a coalition of industry players, government and non-profits to test products and ensure claims are met. For Fried, the most meaningful aspect of his journey is receiving letters from individuals who experienced health benefits after taking Tru Niagen. Looking ahead, Niagen Bioscience aims to solidify its position as the 'gold standard in the NAD+ space,' continuing its scientific leadership. 'Our mission is to help every living being around the world age better. We think what could happen in the next five years is very exciting and special,' Fried concluded.
Hypebeast
9 hours ago
- Hypebeast
From Seoul to the World: Anti Social Social Club Launches 'Designed in Korea' Line
Summary Following the milestone opening of its first global flagship store in South Korea earlier this year,Anti Social Social Club(ASSC) has launched its 'Designed in Korea' capsule collection. The line fuses the brand's early‑era identity with the contemporary creative energy of Seoul, resulting in a curated range of premium apparel and accessories. Each capsule will release in limited quantities, underscoring the label's reputation for exclusivity and collectability. The debut drop features heavyweight tees, fleece, jackets, hats, and accessories, all crafted from elevated materials with meticulous attention to detail. ASSC's Seoul‑based design team revisited the brand's archives to reinterpret signature graphics and silhouettes through a modern Korean lens, creating pieces that balance nostalgia with fresh, street‑ready appeal. Offered in sizes M through 2XL, the range is designed to cater to a broad audience while retaining ASSC's distinctive edge. With prices ranging from $42 – $121 USD, the 'Designed in Korea' line positions itself as an accessible yet premium addition to the streetwear market. Drop 1 is available now exclusively through Anti Social Social Club's officialwebsite.
